Portal de investigación
- Inicio
- Publicaciones
- Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society.
Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Deharo JC
- Dreyfus J
- Bongiorni MG
- Burri H
- Defaye P
- Glikson M
- Lever N
- Mangieri A
- Mondésert B
- Nielsen JC
- Shah M
- Starck CT
- Rao A
- Leclercq C
- Praz F
- Richter S
- Amabile N
- Breitenstein A
- Curila K
- Manlucu J
- Schaller RD
- Tse HF
- Veltmann C
- Whinnett Z
Grupos
Abstract
Up to one-third of patients referred for transcatheter tricuspid valve intervention (TTVI) have a transvalvular pacemaker (PPM) or implantable cardioverter-defibrillator (ICD) lead in place. Both the electrophysiology and interventional cardiology communities have been alerted to the complexity of decision-making in this situation due to potential interactions between the leads and the TTVI material, including the risk of jailing or damage to the leads. This document, commissioned by the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC, reviews the scientific evidence to inform Heart Team discussions on the management of patients with a PPM or ICD who are scheduled for or have undergone TTVI.
© the European Society of Cardiology 2025.
Datos de la publicación
- ISSN/ISSNe:
- 1099-5129, 1532-2092
- Tipo:
- Article
- Páginas:
- -
- PubMed:
- 40163675
- Factor de Impacto:
- 1,957 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
EUROPACE OXFORD UNIV PRESS
Citas Recibidas en Web of Science: 24
Documentos
- No hay documentos
Filiaciones
Keywords
- Transcatheter tricuspid valve intervention; cardiac implantable electronic device lead; lead extraction; lead jailing; tricuspid regurgitation
Campos de Estudio
Cita
Deharo JC,Dreyfus J,Bongiorni MG,Burri H,Defaye P,Glikson M,Lever N,Mangieri A,Mondésert B,Nielsen JC,Shah M,Starck CT,Rao A,Leclercq C,Praz F,Richter S,Amabile N,Breitenstein A,CANO Ó,Curila K,Manlucu J,Schaller RD,Tse HF,Veltmann C,Whinnett Z. Management of patients with transvalvular right ventricular leads undergoing transcatheter tricuspid valve interventions: a scientific statement of the European Heart Rhythm Association and the European Association of Percutaneous Cardiovascular Interventions of the ESC endorsed by the Heart Rhythm Society, the Asian Pacific Heart Rhythm Society and the Canadian Heart Rhythm Society. Europace. 2025. 27. (5):euaf061. IF:10,200. (1).